Reduced dose and reduced exposure to non-vitamin K-antagonist oral anticoagulants: Some considerations on this relationship

被引：1
|
作者：
Rubboli, Andrea [1 ]
Verheugt, Freek W. A. [2 ]
机构：
[1] Osped Maggiore Bologna, Lab Intervent Cardiol, Div Cardiol, Largo Nigrisoli 2, I-40133 Bologna, Italy
[2] OLVG, Heartctr, Dept Cardiol, Oosterpk 9, NL-1091 AC Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 223卷
关键词：
Non-vitamin K-antagonist oral anticoagulants; Oral anticoagulation; ATRIAL-FIBRILLATION; RENAL-FUNCTION; WARFARIN; RIVAROXABAN; DABIGATRAN; APIXABAN; EFFICACY; SAFETY;
D O I：
10.1016/j.ijcard.2016.08.207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：519 / 520
页数：2
相关论文
共 50 条
  • [21] Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Lee, Ki Hong
    Park, Hyung Wook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05): : 583 - 594
  • [22] Stroke Severity in Patients on Non-Vitamin K Antagonist Oral Anticoagulants with a Standard or Insufficient Dose
    Jung, Yo Han
    Choi, Hye-Yeon
    Lee, Kyung-Yul
    Cheon, Kyeongyeol
    Han, Sang Won
    Park, Joong Hyun
    Cho, Han-Jin
    Park, Hyung Jong
    Nam, Hyo Suk
    Heo, Ji Hoe
    Lee, Hye Sun
    Kim, Young Dae
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (12) : 2145 - 2151
  • [23] Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study
    Khan, Faizan
    Lun, Ronda
    Hill, Michael D.
    JAMA INTERNAL MEDICINE, 2024, 184 (05) : 583 - 584
  • [24] Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
    Dincq, Anne-Sophie
    Lessire, Sarah
    Douxfils, Jonathan
    Dogne, Jean-Michel
    Gourdin, Maximilien
    Mullier, Francois
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [25] Non-Vitamin K Antagonist Oral Anticoagulants An Appeal for Consensus on Terminology
    Lip, Gregory Y. H.
    Camm, A. John
    Hylek, Elaine M.
    Halperin, Jonathan L.
    Weitz, Jeffrey I.
    CHEST, 2014, 145 (05) : 1177 - 1178
  • [26] Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation
    Fanaroff, Alexander C.
    Ohman, E. Magnus
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 61 - 75
  • [27] Misdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Primary Care
    Cardoso, Carlos Seica
    Sousa, Joao Andre
    Simoes, Pedro
    Silva, Beatriz
    Albuquerque, Ana
    Esperanca, Ana
    Cibrao, Ana
    Correia, Artur
    Goncalves, Joana
    Mortagua, Joana
    Almeida, Jose Eduardo
    Oliveira, Leonor
    Garcia, Jose
    Duarte, Mariana
    Loureiro, Mariana
    Costa e Silva, Marta
    Fraga, Marta
    Lopes, Paulo
    Brandao, Rui
    Miguel, Susana
    Queiros, Teresa
    Santo, Gustavo
    Silva, Fernando
    Sargento-Freitas, Joao
    CLINICAL THERAPEUTICS, 2020, 42 (06) : 1132 - +
  • [28] Safety of non-vitamin K antagonist oral anticoagulants - coronary risks
    Caldeira, Daniel
    Ferreira, Joaquim J.
    Pinto, Fausto J.
    Costa, Joao
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (06) : 731 - 740
  • [29] Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis
    Ghaffarpasand, Eiman
    Tehrani, Maneli D.
    Marszalek, Jolanta
    Chi, Gerald
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (03) : 332 - 338
  • [30] Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis
    Liu, Zhiyan
    Ma, Lingyue
    Zhang, Hanxu
    Mu, Guangyan
    Xie, Qiufen
    Zhou, Shuang
    Wang, Zining
    Wang, Zhe
    Hu, Kun
    Gong, Yanjun
    Jiang, Jie
    Xiang, Qian
    Cui, Yimin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (06) : 1729 - 1742
12345